Filing status
- Accounts due
- 31 July 2027
- Last accounts
- 31 October 2025
- Conf. stmt due
- 15 July 2027
- Last conf. stmt
- 1 July 2026
Invitro Genetics Limited
- Incorporated
- 3 December 2015 (10 years)
- Industry
- Specialists medical practice activities (86220)
- Directors
- Nigel Anton Penfold
- Owned by
- Accounts type
- Full
- Region
- South East
- Address
- Delta Park Concorde WaySegensworth NorthFarehamPO15 5RL
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 3 August 2026
American
Born July 1979 (47)
Penfold, Nigel Anton
Director · Appointed 5 February 2025
British
Born September 1972 (54)
Officer history (12 former)
3 August 2026
3 August 2026
11 June 2026
5 February 2025
Appointed Penfold, Nigel Anton as Director
5 February 2025
30 March 2021
30 April 2020
15 March 2019
15 March 2019
8 August 2018
8 August 2018
8 August 2018
8 August 2018
8 August 2018
8 August 2018
16 May 2018
2 October 2017
2 October 2017
26 April 2017
18 April 2017
18 April 2017
31 January 2017
31 January 2017
14 December 2015
3 December 2015
3 December 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 9877160
Group structure 5 companies
Ownership group derived from the Companies House PSC register
Invitro Genetics Limited This company Owns 75–100% of shares
Research Instruments Limited Owns 75–100% of shares
Origio Limited Owns 75–100% of shares
Safe Obstetric Systems Limited Owns 75–100% of shares
Financials
Balance sheet as at 31 October 2025 · full accounts
- Net Assets
- £2,158,534
- Cash
- £695,477
- Turnover
- £8,953,685
- Profit Before Tax
- £2,505,403
- Employees
- 24
- Debt Ratio
- 49%
- Current Ratio
- 1.4x
- Profit Margin
- 28%
- Return on Equity
- 87%
Trend
Turnover
Balance sheet detail
| 2025 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Fixed Assets | £1,475,575 | £1,385,535 | £1,629,502 | £1,786,026 |
| Current Assets | £2,761,404 | £2,495,295 | £2,719,677 | £1,824,511 |
| Debtors | £1,317,669 | £921,479 | ||
| Cash | £695,477 | £479,442 | £1,134,841 | £709,517 |
| Creditors (< 1 year) | £1,962,804 | £3,563,651 | £3,776,567 | £3,133,438 |
| Net Current Assets | £798,600 | (£1,068,356) | (£1,056,890) | (£1,308,927) |
| Net Assets | £2,158,534 | £290,182 | £530,382 | £461,691 |
| Shareholder Funds | £2,158,534 | £290,182 | £530,382 | £461,691 |
| Turnover | £8,953,685 | £5,731,802 | £5,523,656 | £3,799,266 |
| Cost of Sales | £3,500,854 | £3,761,123 | £3,263,379 | £3,115,440 |
| Gross Profit | £5,452,831 | £1,970,679 | £2,260,277 | £683,826 |
| Admin Expenses | £2,943,182 | £2,297,634 | £2,034,042 | £1,892,171 |
| Staff Costs | £2,482,064 | £1,966,016 | £2,105,171 | £1,872,041 |
| Operating Profit | (£326,955) | £226,235 | (£3,569,858) | |
| Profit Before Tax | £2,505,403 | (£348,316) | £196,915 | (£3,584,527) |
| Tax | £635,705 | (£108,116) | £128,224 | (£224,551) |
| Profit for Period | £1,869,698 | (£240,200) | £68,691 | (£3,359,976) |
Filings 59
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 August 2026 | Termination of appointment of a director | |||
| 4 August 2026 | Appointment of a director | |||
| 30 July 2026 | Full accounts | 31 October 2025 | ||
| 9 July 2026 | Confirmation statement with no updates | 1 July 2026 | ||
| 18 June 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Cambridge
Scottish Borders
Tunbridge Wells
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →